Skip to content
DataLookout
Start free
Menu

DETECT LTFUNCT07110454

Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 17 versions: 17 with changes below. See every version on ClinicalTrials.gov ↗

  1. Trial sites expanded: 18 → 21 locations
  2. Study sites: 19 to 20
  3. Study sites: 18 to 19
  4. Study sites: 16 to 18
    • Start date changed from estimate of Jun 2026 to Dec 23, 2025
    • Publications: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 5 words
  5. Trial sites expanded: 12 → 16 locationsv13
Show 11 earlier versionsHide 11 earlier versions
  1. Study sites: 11 to 12v12
  2. Study sites: 9 to 11v11
  3. Study sites: 7 to 9v10
  4. Site details revised at 1 of 7 sitesv9
  5. Start date: Jan 2026 to Jun 2026
    • Study sites: 6 to 7
    v8
  6. Study sites: 5 to 6v7
  7. Study sites: 4 to 5v6
  8. Study sites: 3 to 4v5
  9. Study sites: 2 to 3v4
  10. Start date: Nov 20, 2025 to Jan 2026
    • Study sites: 1 to 2
    v3
  11. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Nov 2025 to Nov 20, 2025
    • Publications: details revised at 1 of 1 entry
    v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

To evaluate the Minder System to aid in treatment following an actionable event by comparing change using the Patient Global Impression scale (PGIC) from baseline to follow-up.
Timeframe: 2 years

Arms and interventions

Observational

Minder System

Devices: Previous receipt of the Minder System (implantable continuous electroencephalographic (EEG) monitoring (iCEM) system)

Sites

21 sites in 1 country